Data as of .
FMED vs XDAT: which is really different?
FMED and XDAT hold 0% of their weight in the same names, and FMED returned more over the year.
ETFIQ Off-Index Score: FMED scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
0% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, FMED and XDAT hold 0% of their money in the same securities at the same weight.
| Only in FMED | Only in XDAT |
|---|---|
| UCB SA 4.75% | CLOUDFLARE INC 10.14% |
| LIFESTANCE HEALTH GROUP INC 4.29% | ALPHABET INC 9.76% |
| DANAHER CORP 3.43% | META PLATFORMS INC 6.43% |
| 10X GENOMICS INC 3.12% | SNOWFLAKE INC 5.03% |
| INTUITIVE SURGICAL INC 2.93% | APPLOVIN CORP 5.02% |
| COGENT BIOSCIENCES INC 2.86% | PALO ALTO NETWORKS INC 4.54% |
| ALNYLAM PHARMACEUTICALS INC 2.80% | CROWDSTRIKE HOLDINGS INC 4.39% |
| ARGENX SE 2.79% | DATADOG INC 4.11% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| FMED | XDAT | FMED | XDAT | FMED | XDAT | |
| 3 months | +21.3% | +10.6% | +19.0 pts | +8.3 pts | +23.7 pts | +13.1 pts |
| 6 months | +32.3% | +23.9% | +14.3 pts | +5.9 pts | +8.0 pts | −0.3 pts |
| 1 year | +28.3% | −4.8% | +11.7 pts | −21.4 pts | +6.5 pts | −26.6 pts |
| 3 years | +39.6% | +47.1% | −38.8 pts | −31.3 pts | −58.5 pts | −51.1 pts |
| Since launch | +25.8% | +9.1% | −57.6 pts | −108.2 pts | −78.1 pts | −127.9 pts |
| FMED Fidelity Disruptive Medicine ETF Holds 68 stocks in broad innovation and megatrends, 25% of its weight in S&P 500 companies | XDAT Franklin Exponential Data ETF Holds 59 stocks in broad innovation and megatrends, 61% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | Fidelity | Franklin |
| Theme | Broad innovation and megatrends | Broad innovation and megatrends |
| In the S&P 500 | 25.4% | 61.1% |
| Active share vs the S&P 500 | 97.1% | 86.2% |
| In the Nasdaq-100 | 8.7% | 49.6% |
| Holdings | 68 | 59 |
| Top ten, share of the fund | 31.5% | 56.7% |
| Expense ratio | 0.50% | 0.50% |
| Fee for the differing part | 0.51% | 0.58% |
| Total return, 1 year | +28.3% | −4.8% |
| vs the S&P 500 | +11.7 pts | −21.4 pts |
| vs the Nasdaq-100 | +6.5 pts | −26.6 pts |
| Below its high | −3.8% | −12.3% |
| Net assets | $52m | $4m |
FMED in plain words
By weight, 25% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 32% of the fund across 68 positions, as filed for May 31, 2026. Over the year to Sep 18, 2026 the fund returned +28.3% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 11.7 pts.
XDAT in plain words
By weight, 61% of XDAT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 86%. The top ten holdings are 57% of the fund across 59 positions, as filed for Jun 30, 2026. Over the year to Sep 18, 2026 the fund returned −4.8% with distributions reinvested against +16.6% for the S&P 500, so a holder was behind by 21.4 pts. It sits 12.3% below its all-time high of Nov 9, 2021.
Questions people ask
- Do FMED and XDAT hold the same stocks?
- By their latest filings, 0% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, FMED or XDAT?
- FMED has 25% of its weight in S&P 500 names and XDAT has 61%, so FMED differs more from the index.
- Which is cheaper, FMED or XDAT?
- FMED charges 0.50% a year and XDAT charges 0.50%, so FMED is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, FMED against XDAT, data as of Sep 18, 2026. https://etfiq.com/compare/themes/fmed-vs-xdat Free to use with attribution; the underlying files are at Open data.